M ortality rates from acute myocardial infarction (AMI) have been declining since the 1980s in Australia and other Western countries, driven both by declines in event rates and case fatality rates. 1, 2 However, these declines may not have benefitted all population groups equally. Australia's Aboriginal and Torres Strait Islander peoples experience a significant health gap compared with other Australians and ischemic heart disease is a leading contributor to this gap. 3 Age-adjusted case fatality after AMI has been estimated to be 1.5 times higher for Aboriginal people compared with other Australians. 4 To improve case fatality and mortality rates and improve the gap in burden of disease it is important that Aboriginal patients receive the best possible treatment in hospital after admission for AMI. disparity in revascularization rates for Aboriginal and non-Aboriginal patients.
Using linked data and multilevel modelling, this study aimed to (1) compare rates of revascularization procedures between Aboriginal and non-Aboriginal patients admitted with AMI, (2) quantify the influence of the admitting hospital on differences in revascularization rates; and (3) explore the role of patient and hospital factors in any disparities.
Methods

Study Design
The study was an observational cohort study using linked populationbased administrative data sets.
Setting
Australia has a universal health care system with free public acute hospital services and a large private sector including private hospitals and private care within the public hospitals. 15 New South Wales (NSW) is the most populous state in Australia with 6.8 million residents in 2006, 2.2% of whom identified as Aboriginal or Torres Strait Islander. 16 Approximately 30% of Australia's Aboriginal peoples live in NSW, the largest percentage of the States and Territories in Australia. 16 In 2006, 73% of the total NSW population lived in a major city 17 compared with 42% of the Aboriginal population. 18 
Data Sources
The NSW Admitted Patient Data Collection from July 1, 2000 to December 31, 2008 was linked to mortality data for the same period. The Admitted Patient Data Collection includes all public and private hospital admissions ending in a discharge, transfer, type-change, or death. Diagnoses were coded according to the Australian modification of the International Statistical Classification of Diseases and Related Problems 10 th Revision (ICD-10-AM, introduced in July 1998) and procedures according to the Australian Classification of Health Interventions. 19 The datasets were linked probabilistically using identifying fields by an independent third party organization, the Center for Health Record Linkage, 20 and researchers were supplied with deidentified records including a project-specific person number.
Study Sample
The study sample subjects were all NSW residents aged 25 to 84 years who were first admitted to a public hospital in NSW with an admission classified as both acute care and emergency and with a primary diagnosis of AMI (ICD-10-AM I21) or an AMI recorded in the second or third diagnosis field along with a primary diagnosis of ischemic heart disease (ICD-10-AM I20-I25). The first such admission in the period July 2001 to November 2008 was chosen as the index admission for analysis, leaving a clearance period of at least 12 months and follow-up of 30 days. It was not possible to exclude all prevalent cases of AMI, because of the limited years of linked data available, and thus the cohort consisted of patients with their first ever AMI admission and those who may have had an AMI admission before July 2000. Patients were excluded if they had missing data for key variables (n=241), inconsistent date of death or procedure (n=17), or appeared to be duplicate admissions (n=5). The final data set included a total of 59 282 patients (n=1165 Aboriginal and n=58 117 non-Aboriginal) who were first admitted to 174 public hospitals.
Variables
Patients were followed in the dataset after their index AMI admission to determine whether they received a revascularization procedure (ie, a percutaneous coronary intervention [PCI] or a coronary artery bypass graft [CABG]) within 30 days, at any hospital (public or private) in NSW. The time to first angiography procedure was also recorded, with the assumption that all those with a revascularization recorded had an angiography procedure at the same time, if not separately recorded. The main explanatory variable of interest was whether the patient was Aboriginal or Torres Strait Islander (referred to as Aboriginal), which is routinely recorded in the hospital data. A recent audit of the Australian hospital data estimated that Aboriginal people are correctly identified on 88% of admissions in NSW public hospitals. 21 To enhance identification, we defined a person as Aboriginal based on their most recent admission. This enhanced the number of admissions identified as Aboriginal by 10% in the total hospital data.
Other variables of interest were as follows: age, sex, AMI type, comorbidities, private health insurance, substance use, remoteness, socio-economic status (SES), and hospital characteristics. AMI type was divided into ST-elevated myocardial infarction (ICD-10-AM I21.0-I21.3), non-ST-elevated myocardial infarction (I21.4), and unspecified (I21.9). The comorbidities included in the models were those that may impact on provision of revascularization procedures or outcomes after AMI, as determined by a literature search: shock, diabetes mellitus with complications, congestive heart failure, cancer, cerebrovascular disease, pulmonary edema, acute renal failure, chronic renal failure, cardiac dysrhythmias; 22 and chronic obstructive pulmonary disease, diabetes mellitus without complications, and depression. 8 Comorbidities and substance use (current smoking status [ICD-10-AM F17.1, F17.2, Z72.0] and alcohol and drug abuse) 23 were collated from all secondary diagnosis codes recorded at the index admission and from any diagnosis field in linked hospital admissions up to 12 months prior. Patients were identified as having private health insurance if they had private payment status or private insurance status recorded on the index AMI admission or any admission up to 12 months prior.
Remoteness of residence was classified according the Accessibility/ Remoteness Index of Australia (ARIA+) score for each person's Statistical Local Area of residence at the time of index admission. ARIA+ measures remoteness based on the road distance to 5 categories of service centers that are classified according to their population size as a proxy for availability of services. 24 SES was determined using the Australian Bureau of Statistics Socio-Economic Index for Areas Index of Relative Socioeconomic Disadvantage (SEIFA IRSD, divided into population quintiles) assigned to the Statistical Local Area of residence at the time of admission. 25 Three hospital-level variables were hospital remoteness (ARIA+ of the hospital based on postcode area), hospital size (average number of total acute admissions per year from 2001-2008 divided into 5 groups at the 50 th , 75 th , 85 th and 95 th percentiles for hospitals), and the level of catheterization facilities available (24/7 catheterization laboratory, catheterization laboratory but not 24/7, or no catheterization laboratory). Finally, a flag for those hospitals transferring >10% of their AMI patients to an interstate hospital (ie, smaller hospitals near the State border) was included to correct for any bias resulting from differential rates of interstate transfer, and also to better quantify the variation in revascularization rates between NSW hospitals.
Statistical Analysis
Characteristics of Aboriginal and non-Aboriginal AMI patients, and of the admission and hospital, were compared using χ 2 tests. Because of the differences in the demographic profile of Aboriginal and non-Aboriginal people, particularly by age, the prevalence of comorbidities among Aboriginal and non-Aboriginal patients as determined from the admission record and any admission in the previous year was compared using age-, sex-, and year-adjusted prevalence ratios calculated using a Poisson model with robust error variances. 26 The relationship between comorbidities and the likelihood of revascularization was examined using age-, sex-, and year-adjusted hazard ratios from single-level Cox regression models with time to revascularization within 30 days of the index AMI admission as the outcome. Single-level and multilevel Cox regression models examined factors that were associated with time to procedure within 30 days of index AMI admission. Models were run for the following procedures: all revascularization, PCI and CABG separately, and angiography. The single-level models compared procedure rates among covariate-adjusted Aboriginal and non-Aboriginal people, whereas the random intercept multilevel models compared rates for covariate-adjusted Aboriginal and non-Aboriginal people admitted to the same hospital, by including a random intercept for hospital of admission. Cox regression was used to censor patients who died before receiving a procedure or were lost to follow-up as a result of transfers. Cox regression produces a hazard ratio which is similar to a relative risk, describing the relative likelihood of receiving a procedure at any point in time in the first 30 days after the index admission. The multilevel Cox regression models also examined between-hospital variation in the outcome to assess the impact of hospital of admission on time to procedure. The betweenhospital variation, or hospital-level variance (τ 2 ), was also expressed as a median hazard ratio, which was the median of the hazard ratios of pair-wise comparisons of patients with identical characteristics taken from randomly chosen hospitals. This was an extension of the technique described by Merlo et al 27 for calculating median odds ratios for multilevel logistic regression models and was calculated using the formula, median hazard ratio = exp(0.95√τ 2 ). Data analyses were carried out in SAS 9.2 28 and MLwiN 2.24. 29
Ethics
Ethics approval for the study was given by the Population Health Services Research Ethics Committee, the Aboriginal Health and Medical Research Council Ethics Committee, and the University of Western Sydney Ethics Committee.
Results
Patient Characteristics
Among those admitted for AMI, Aboriginal patients were more likely than non-Aboriginal patients to be younger, female, current smokers, have alcohol or drug abuse recorded in hospital, be without private health insurance, living in more disadvantaged areas, and living in regional and remote areas of NSW (Table 1) . Aboriginal patients were also more likely to be first admitted to hospitals outside of major cities, with a lower volume of acute admissions per year and without any catheterization laboratory. Before any adjustments, about one-third (32.9%) of Aboriginal patients with AMI had a revascularization procedure, and 48.5% had an angiography procedure, within 30 days, compared with 39.7% and 54.3% of non-Aboriginal patients, respectively. Overall, there were ≈3× as many PCI procedures as CABG procedures. Aboriginal patients had a significantly lower rate of PCI procedures than non-Aboriginal people but there was no significant difference in the rate of CABG procedures.
Aboriginal patients had significantly higher age-, sex-, and year-adjusted prevalence of a number of conditions associated with lower revascularization rates ( Figure) , including diabetes mellitus with and without complications, chronic obstructive pulmonary disease, chronic and acute renal failure, congestive heart failure, and cerebrovascular disease.
Disparity in Revascularization Rates
Cox regression models examining the hazard of receiving a revascularization within 30 days of admission were built up with sequential addition of covariates and a random intercept for hospital ( When the final adjusted model (Model 8) was rerun for PCI and CABG separately it showed that, although not significant, Aboriginal patients had higher hazard of a CABG procedure than non-Aboriginal patients (adjusted hazard ratio, 1.19; 95% CI, 0.96-1.47; P=0.11), and lower hazard of a PCI revascularization (adjusted hazard ratio, 0.93; 95% CI, 0.82-1.05; P=0. 21) .
A sequential analysis was run for angiography within the first 30 days after AMI. These results were similar to the revascularization results: there was a large disparity between Aboriginal and non-Aboriginal people after adjusting for age, sex, year, and AMI type (0.62; 95% CI, 0.57-0.67); a reduction once accounting for admitting hospital (0.81; 95% CI, 0.74-0.88); and no significant disparity remaining after adjusting for comorbidities, substance use, and private health insurance (0.94; 95% CI, 0.87-1.03). Table 3 shows the hazard ratios for selected covariates from the final adjusted model for revascularization within 30 days (Model 8). Revascularization was less likely for females, younger (25-34 years) and older (75-84 years) age groups, those classified as non-ST-elevated myocardial infarction or unspecified AMI type, those with alcohol abuse recorded, and those with any of the comorbid conditions apart from shock, particularly dementia. Patients with shock, current smokers, and those with private health insurance were more likely to be revascularized within 30 days. There was no significant variation in revascularization rates by quintiles of SES based on area of residence. However, area of residence was closely associated with hospital of first admission, which was already being accounted for in the multilevel model. Comparing patients within hospitals, those living in inner regional areas were slightly more likely to be revascularized than those living in a major city.
Individual Characteristics Associated With 30-Day Revascularization
Influence of Hospital on 30-Day Revascularization
Significant variance at the hospital level remained after adjusting for individual covariates and the interstate transfer of patients (τ 2 =0.264, P<0.01; Model 8). This equated to a median hazard ratio of 1.63, meaning that an AMI patient had a (median) 63% greater rate of being revascularized within 30 days than a patient with identical characteristics who went to a hospital with a lower revascularization rate. To determine what factors were influencing this hospital-level variation, 3 hospital-level covariates (hospital remoteness, hospital size, and presence of a catheterization laboratory) were added to the fully adjusted model (Model 8) one at a time (because they February 19, 2013 were highly associated). Revascularization within 30 days was significantly less likely for patients admitted to nonmajor city hospitals (Model 9, Table 4 ), smaller hospitals with <18 400 acute admissions per year (Model 10, Table 4 ), or hospitals without catheterization laboratories (Model 11, Table 4 ). Even those admitted to a hospital with catheterization, but not a 24/7 laboratory, were significantly less likely to be revascularized within 30 days than those admitted to a hospital with 24/7 catheterization. When all of the above hospital-level covariates were included in the model at once, they accounted for 51% of the residual variation between hospitals. ‡Accessibility/Remoteness Index of Australia (ARIA+) based on statistical local area of residence or postcode of hospital.
§The number of PCI and CABG procedures will not add to the total revascularization procedures, as a person could have had >1 procedure within 30 days. 
Table 1. Distribution of Characteristics and Outcomes by Aboriginal and Non-Aboriginal People Admitted With Acute Myocardial Infarction
Discussion
Our results showed that Aboriginal patients had a 37% (30%-43%) lower rate of revascularization at any point in the first 30 days after admission with AMI compared with non-Aboriginal people of the same age, sex, year of admission, and AMI type. However, this did not account for the fact that Aboriginal people were more likely to be first admitted to smaller hospitals without specialist cardiac facilities. This is attributable to proportionately fewer Aboriginal people living in major cities near the larger hospitals. 18 After additional adjustment for hospital of admission, Aboriginal patients had an 18% (9%-26%) lower rate of revascularization compared with covariate-adjusted non-Aboriginal patients first admitted to the same hospital. Thus, much of the observed population-level disparity was driven by the hospital of admission.
These results contrast with those reported in racial disparities research from the USA: when the hospital of admission was accounted for in an analysis of Medicare patients, the disparity in the rate of revascularization procedures between black and white Americans increased. 6 This may be because black Americans are more likely than white Americans to live in cities and closer to larger hospitals. 30 Unlike in the US, the disparity in revascularization rates for Aboriginal Australians is related to rural disparities in cardiac care.
Even so, in the current study, a disparity between Aboriginal and non-Aboriginal people remained after adjustment for hospital of admission. This was further reduced once comorbidities were accounted for, with Aboriginal patients now having a 10% (0%-19%) lower rate of revascularization than covariate-adjusted non-Aboriginal patients. For some of these comorbidities, revascularization may be contraindicated: deterioration in renal function in patients with chronic renal failure is a risk after contrast administration for angiography or the use of cardiopulmonary bypass. 31 However, one study found survival benefits after revascularization for high-risk non-ST elevated acute coronary syndrome patients, who were more likely to have diabetes mellitus and previous heart failure, and did not find the same benefits for the Figure. Adjusted hazard ratios for likelihood of being revascularized by selected comorbidities,* and adjusted Aboriginal to non-Aboriginal prevalence rate ratios for the same comorbidities, adjusted by age, sex, and year of admission. CI indicates confidence interval; COPD, chronic obstructive pulmonary disease; HR, hazard ratio; and RR, rate ratio. *Comorbidities that could impact on revascularization rates or outcomes after AMI, chosen from literature search. 32 Updated research is needed on whether revascularization confers an overall benefit for those with a high comorbidity burden, given recent improvements in surgical techniques. 33 Our finding that those with shock had a higher likelihood of receiving a revascularization procedure than those without may be attributable to the SHOCK trial 34 showing evidence for the benefit of revascularization for this high-risk patient group. In our study, much of the remaining disparity in revascularization rates was accounted for when substance use and private health insurance were added to the model, leaving a nonsignificant 4% (−7% to 13%) disparity. Because of the universal health system in Australia, one would not necessarily expect differences in revascularization rates by health insurance status, however higher rates of revascularization procedures particularly for privately insured patients in private hospitals has been shown previously in Australia. 35 The reasons for this are complex. Those with private health insurance may be more likely to get discretionary procedures and may be overtreated. Also, in the Australian context, private health insurance may be a proxy for individual SES. The reduction in racial disparities once private health insurance was accounted for in the current study differs from results on racial disparities in the USA, where racial disparities persisted after controlling for insurance status. 8 Other studies in Australia have found disparities in revascularization rates for Aboriginal compared to non-Aboriginal patients of between 7% and 40%. 4, 12, 13, 36 It is difficult to directly compare these findings with ours, because of differences in methods, study populations, and the level of adjustment in models. Overall, it appears that Aboriginal people receive fewer revascularization procedures than age-adjusted non-Aboriginal people, but once factors such as area of residence, hospital of admission, comorbidity burden, or private health insurance are taken into account, the disparity reduces.
Similar to our study, another Australian study has shown higher rates of CABG procedures among Aboriginal compared with non-Aboriginal patients. 36 Explanations for this might include the following: more extensive coronary artery disease and diabetes mellitus in Aboriginal patients, for which CABG may be the clinically preferred therapy 37 or clinician concern about rates of stent thrombosis (a rare but dangerous complication of PCI) for Aboriginal patients. Clinicians may be concerned about compliance with antiplatelet therapy, 38 particularly if the patient is returning to a rural or remote community where follow-up is less certain; however we could find no research on differential rates of antiplatelet therapy compliance or rates of stent thrombosis for Aboriginal and non-Aboriginal patients.
We repeated the revascularization analysis using the time to first angiography, which showed very similar results confirming that the disparities in revascularization rates were not attributable to differences in angiography results but rather that Aboriginal people with AMI were not getting the same rate of angiography or revascularization as non-Aboriginal people.
After adjusting for all individual covariates and transfer of patients interstate, hospitals varied markedly in the 30-day revascularization rates, with a median 63% higher rate of a revascularization for patients first admitted to hospitals with a higher rates of revascularization. This level of influence of admitting hospital is on par with the influence of individual characteristics such as age, sex, AMI type, and some comorbidities, and was stronger than the hospital-level impact on 30-day mortality after AMI admission where a median odds ratio of 1.34 was found. 39 This reflects the direct influence of the practices of a hospital and its clinicians on procedure rates.
In the current study, half of the hospital-level variation in revascularization rates after AMI was explained by hospital size, presence, and level of on-site cardiac facilities and remoteness of the hospital. However, these measured hospital-level factors might have been correlated with other unmeasured factors such as the time taken for the patient to get to hospital after AMI onset. 40 Communication and coordination between those hospitals capable of performing revascularization and those not, electrocardiograms in ambulances and activation of catheterization laboratories, have been shown to improve time to revascularization 41, 42 and are part of new models of care being rolled out in Australia. 43 It will be important to monitor the impact of these new models of care to ensure that they contribute to a reduction in the overall state-wide disparity in revascularization rates for Aboriginal people.
Increasing revascularization rates is only part of the story in reducing the gap in mortality from AMI for Aboriginal Australians. International studies have estimated that 50% or more of the decrease in AMI mortality in Western countries since the 1980s has been a result of a reduction in event rates. 1, 2 Primary and secondary prevention are key factors to not only reducing the incidence of AMI for Aboriginal people in Australia but also decreasing the levels of comorbidity or better managing chronic conditions that may contribute to lower rates of revascularization.
The strengths of this study were in the comprehensive population coverage of the admitted patient data, as well as the linkage that allowed us to track patients from one hospital to another and censor those who died. However, there were limitations to using administrative data. The data were not collected for research purposes and thus were missing information on some clinical indications such as extent of coronary artery disease. That said, we adjusted for the presence of comorbidities and risk factors associated with revascularization in our models. Also, we were unable to identify which patients were given thrombolysis, and as a result, may not have needed a revascularization procedure. However, systematic hospital-level differences in the likelihood of administering thrombolysis as a result of size and remoteness would have been accounted for by the random hospital effect in the multilevel models that compared treatment rates within hospital. Additionally, the administrative data were missing information about patient preference, refusal, or physician attitudes or recommendations. The administrative data were for NSW hospitals only, and therefore, if someone was transferred to another hospital outside of NSW for their procedure they were lost to follow-up. We accounted for this when quantifying the impact of hospital of admission on variation in procedure rates and also confirmed that there was no impact of this cross-border flow on the adjusted Aboriginal to non-Aboriginal hazard ratio.
Conclusions
Our study shows that the overall disparity in revascularization rates for Aboriginal compared with non-Aboriginal Australians was associated with lower revascularization rates for all patients admitted to smaller regional and rural hospitals and, among Aboriginal patients, a higher burden of chronic conditions such as diabetes mellitus, chronic obstructive pulmonary disease, and renal failure and lower levels of private health insurance. These findings can potentially be generalized to minority populations worldwide that suffer the dual disadvantage of low SES, and residence in rural and remote areas with limited access to specialist services. 
